Venturi Wealth Management LLC Has $928,000 Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)

Venturi Wealth Management LLC grew its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 13.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,092 shares of the medical instruments supplier’s stock after purchasing an additional 368 shares during the period. Venturi Wealth Management LLC’s holdings in West Pharmaceutical Services were worth $928,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Mizuho Markets Americas LLC grew its position in shares of West Pharmaceutical Services by 142.3% during the 1st quarter. Mizuho Markets Americas LLC now owns 29,628 shares of the medical instruments supplier’s stock worth $11,724,000 after purchasing an additional 17,399 shares in the last quarter. Tidal Investments LLC grew its position in shares of West Pharmaceutical Services by 54.7% during the 1st quarter. Tidal Investments LLC now owns 10,574 shares of the medical instruments supplier’s stock worth $4,181,000 after purchasing an additional 3,738 shares in the last quarter. Bahl & Gaynor Inc. grew its position in shares of West Pharmaceutical Services by 70.1% during the 1st quarter. Bahl & Gaynor Inc. now owns 4,976 shares of the medical instruments supplier’s stock worth $1,969,000 after purchasing an additional 2,050 shares in the last quarter. Swedbank AB acquired a new position in shares of West Pharmaceutical Services during the 1st quarter worth approximately $1,937,000. Finally, Cetera Investment Advisers grew its position in shares of West Pharmaceutical Services by 525.1% during the 1st quarter. Cetera Investment Advisers now owns 18,990 shares of the medical instruments supplier’s stock worth $7,515,000 after purchasing an additional 15,952 shares in the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

Insider Buying and Selling

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 703 shares of the firm’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $310.40, for a total value of $218,211.20. Following the sale, the vice president now owns 1,253 shares in the company, valued at $388,931.20. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.53% of the stock is currently owned by company insiders.

West Pharmaceutical Services Stock Performance

Shares of NYSE:WST opened at $327.65 on Tuesday. The company has a quick ratio of 2.23, a current ratio of 3.00 and a debt-to-equity ratio of 0.07. The firm has a market cap of $23.73 billion, a PE ratio of 48.61, a PEG ratio of 24.51 and a beta of 1.00. The company’s 50 day moving average price is $303.61 and its two-hundred day moving average price is $316.64. West Pharmaceutical Services, Inc. has a 12-month low of $265.00 and a 12-month high of $413.70.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.50 by $0.35. The business had revenue of $746.90 million for the quarter, compared to analyst estimates of $709.62 million. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. The firm’s revenue for the quarter was down .1% on a year-over-year basis. During the same quarter last year, the business posted $2.16 EPS. Equities research analysts predict that West Pharmaceutical Services, Inc. will post 6.66 earnings per share for the current year.

West Pharmaceutical Services Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 20th. Investors of record on Wednesday, November 13th will be given a dividend of $0.21 per share. This is a positive change from West Pharmaceutical Services’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.84 annualized dividend and a dividend yield of 0.26%. West Pharmaceutical Services’s dividend payout ratio (DPR) is currently 12.46%.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.